May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Intravitreal Transplantation of Oligodendrocyte Precursor Cells Increases Retinal Ganglion Cell Survival in a Rat Glaucoma Model
Author Affiliations & Notes
  • N. D. Bull
    University of Cambridge, Cambridge, United Kingdom
    Dept Clinical Neurosciences,
  • K. A. Irvine
    University of Cambridge, Cambridge, United Kingdom
    Dept of Veterinary Medicine,
  • R. J. M. Franklin
    University of Cambridge, Cambridge, United Kingdom
    Dept of Veterinary Medicine,
  • K. R. Martin
    University of Cambridge, Cambridge, United Kingdom
    Dept Clinical Neurosciences,
  • Footnotes
    Commercial Relationships  N.D. Bull, None; K.A. Irvine, None; R.J.M. Franklin, None; K.R. Martin, None.
  • Footnotes
    Support  GSK Clinician Scientist Fellowship (KRM), Addenbrooke's Hospital (Cambridge) and the Glaucoma Research Foundation.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 4064. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. D. Bull, K. A. Irvine, R. J. M. Franklin, K. R. Martin; Intravitreal Transplantation of Oligodendrocyte Precursor Cells Increases Retinal Ganglion Cell Survival in a Rat Glaucoma Model. Invest. Ophthalmol. Vis. Sci. 2008;49(13):4064. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Oligodendrocyte precursor cells (OPCs) have previously been shown to myelinate retinal ganglion cell (RGC) axons when transplanted intravitreally. The extent of myelination is enhanced in the presence of zymosan. We investigated whether transplantation of OPCs can reduce RGC death in a rat glaucoma model.

Methods: : OPCs were isolated and cultured from the cortices of P0 Lewis rat pups. Adult Lewis rats received intravitreal transplantation of either OPCs plus zymosan (n=9) or zymosan alone (n=9). Eight weeks after transplantation, experimental glaucoma was induced in the transplanted eye by 532nm trabecular laser treatment. Optic nerve axon survival was quantified after 4 weeks of experimental glaucoma and immunohistochemical techniques were used to assess OPC/oligodendrocyte survival and myelination.

Results: : Axon counts revealed that engraftment of OPCs provided significant RGC neuroprotection with 69917±9302 axons surviving in OPC plus zymosan treated eyes compared to 40671±7465 axons remaining in control zymosan treated eyes (mean±SEM; p=0.03). Axonal loss relative to the untreated fellow eye was 28.34±11.51% in OPC plus zymosan treated eyes compared to 60.34±8.28% in eyes treated with zymosan alone (mean±SEM; p=0.05). Surprisingly, immunohistochemical analysis of retinal flat-mounts showed limited myelination of RGC axons by OPCs or differentiation of OPCs into oligodendrocytes.

Conclusions: : Intraocular engraftment of OPCs provided significant RGC neuroprotection, reducing axonal loss by about 50% after 4 weeks of glaucoma. Our observation of increased RGC survival, even when OPCs were transplanted 2 months prior to experimental IOP elevation, suggests a prolonged neuroprotective effect of this treatment.

Keywords: neuroprotection • ganglion cells • transplantation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×